SCHEMBL9068006

SCHEMBL9068006

COC(CO)C(O)(OC)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.35
CES1 P23141 1/20 0.34
ALDH1A1 P00352 2/20 0.33
CYP2C19 P33261 2/20 0.33
KCNN4 O15554 1/20 0.33
CYP2D6 P10635 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CHRM3 P20309 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 2/20 0.33
TTR P02766 1/20 0.33
ALOX15 P16050 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
SRC P12931 1/20 0.31
MAPK1 P28482 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycolic Acid SCHEMBL30111933 0.93 CES1 (0.36) KIF11CES1CYP2C19KCNN4CYP2D6
SCHEMBL5069848 0.79 KIF11 (0.38) KIF11CYP2C19CYP2D6CYP2C9
SCHEMBL5483343 0.77 CES1 (0.37) CES1ALDH1A1CYP2C19KCNN4CYP2D6
SCHEMBL8906872 0.71 NR1H2 (0.32) CHRM3MEN1KMT2A
SCHEMBL2205526 0.71 NR1H2 (0.32) CHRM3MEN1KMT2A
SCHEMBL10591561 0.68 ESR2 (0.36) KIF11ALDH1A1MEN1KMT2AKDM4E
SCHEMBL5133753 0.68 CES1 (0.44) CES1ALDH1A1CYP2C19KCNN4KMT2A
SCHEMBL6855004 0.67 CES1 (0.40) KIF11CES1ALDH1A1CYP2C19KCNN4
SCHEMBL3205214 0.63 KCNN4 (0.41) KIF11CES1ALDH1A1CYP2C19KCNN4
SCHEMBL6671847 0.63 CYP2C19 (0.42) ALDH1A1CYP2C19CYP2D6HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427458-A Transglutaminase mediated conjugation 塔拉克治疗公司 2022-12-02 CN disclosed
WO-1996034008-A1 NOVEL ANTISENSE NUCLEIC ACIDS DIRECTED AGAINST RAS ONCOGENES, THEIR PREPARATION AND USE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1996-10-31 WO disclosed